Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer.
Ribeiro ARG, Salvadori MM, de Brot L, Bovolin G, Mantoan H, Ilelis F, Rezende M, do Amaral NS, Sanches SM, Maya JML, Dos Santos ES, Pereira R, de Souza Castro F, da Nogueira Silveira Lima JP, Guimarães APG, Baiocchi G, da Costa AABA.
Ribeiro ARG, et al.
Ecancermedicalscience. 2021 Jul 5;15:1262. doi: 10.3332/ecancer.2021.1262. eCollection 2021.
Ecancermedicalscience. 2021.
PMID: 34567247
Free PMC article.